ArticleAmerican journal of clinical dermatology2025

Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study.

Francesco Leo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.